Results 121 to 130 of about 4,299 (147)

Research priorities in Fontan-associated liver disease

Current Opinion in Organ Transplantation, 2020
Purpose of reviewFontan-associated liver disease (FALD) is an emerging condition in patients who have undergone surgical correction of univentricular congenital heart disease. There is little known about the epidemiology of FALD, including risk factors for end-organ failure or hepatocellular carcinoma nor a consensus on surveillance guidelines ...
Sara, Khan, Hassan, Aziz, Juliet, Emamaullee   +2 more
openaire   +2 more sources

Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management

Seminars in Liver Disease, 2021
AbstractFontan-associated liver disease is the term used to encompass the disorders arising from abnormal hemodynamic alterations and systemic venous congestion after the Fontan procedure. The histological changes produced in the liver are similar but not equivalent to those seen in other forms of cardiac liver disease.
Luis Téllez, Enrique Rodríguez de Santiago, Agustín Albillos   +2 more
openaire   +2 more sources

Fontan‐associated liver disease after heart transplant

Pediatric Transplantation, 2022
AbstractBackgroundFontan associated liver disease (FALD) potentially impacts Fontan patients undergoing heart transplant. This multi‐center study sought to identify pre‐transplant risk factors and characterize any post‐transplant liver recovery in those patients undergoing heart‐alone transplant.MethodsReview of Fontan patients at 12 pediatric ...
Eric R. Griffiths, Linda M. Lambert, Zhining Ou, Akraam Shaaban, Maryam Rezvani, Waldemar F. Carlo, Kurt R. Schumacher, Frank DiPaola, Matthew J. O'Connor, Deipanjan Nandi, Steven Zangwill, Michael A. McCulloch, Joshua M. Friedland‐Little, Shawn C. West, Teresa M. Lee, Juan C. Alejos, Sharon Chen, Kimberly M. Molina   +17 more
openaire   +3 more sources

Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence

Seminars in Thoracic and Cardiovascular Surgery, 2022
Fontan associated liver disease (FALD) has been recognized as a potentially serious sequela of the Fontan circulation. Prevalence of FALD among different age groups and risk factors for advanced changes were assessed. FALD screening included abdominal ultrasound and laboratory tests. A "liver disease score (LDS)" incorporating items from ultrasound and
Jan Hinnerk Hansen, Joshua Kian Khodami, Jörg Detlev Moritz, Katy Rinne, Inga Voges, Jens Scheewe, Hans-Heiner Kramer, Anselm Uebing   +7 more
openaire   +2 more sources

Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics [PDF]

Pediatric Cardiology, 2020
AbstractFontan-palliated patients are at risk for the development of Fontan-associated liver disease (FALD). In this study, we performed a detailed hemodynamic and hepatic assessment to analyze the incidence and spectrum of FALD and its association with patients' hemodynamics.
Anastasia Schleiger, Peter Kramer, Friederike Danne   +2 more
exaly   +3 more sources

Fontan-Associated Liver Disease: A Review

Cardiology in Review
Fontan-associated liver disease (FALD) is a chronic complication of the Fontan procedure, a palliative surgery for patients with congenital heart disease that results in a single-ventricle circulation. The success of the Fontan procedure has led to a growing population of post-Fontan patients living well into adulthood.
Gabriel, Heering, Nachum, Lebovics, Raksheeth, Agarwal, William H, Frishman, Edward, Lebovics   +4 more
openaire   +2 more sources

Portal vein thrombosis in Fontan-associated liver disease

Cardiology in the Young, 2020
AbstractA 25-year-old patient with signs of cirrhosis on ultrasound and CT presented with portal vein thrombosis on routine follow-up examinations; retrograde hepatic wedge angiography demonstrated only the right-sided portal vein branch. Development of a portosystemic collateral vessel to the left-sided renal vein prevented signs of hypersplenism ...
Renate Kaulitz, Ludger Sieverding, Michael Hofbeck   +2 more
openaire   +2 more sources

Fontan-associated liver disease: Spectrum of US findings

European Journal of Radiology, 2016
To describe ultrasonography (US) findings of Fontan-associated liver disease (FALD) and to determine whether screening US examinations can identify FALD before biochemical hepatic dysfunction.This retrospective study included 55 patients who underwent Fontan procedure over a 20-year period.
Jung Min, Bae, Tae Yeon, Jeon, Jung Sun, Kim, Seokhwi, Kim, Sook Min, Hwang, So-Young, Yoo, Ji Hye, Kim   +6 more
openaire   +2 more sources

Fontan associated liver disease: Is elastography useful?

Progress in Pediatric Cardiology, 2020
Abstract Introduction Fontan associated liver disease (FALD), can manifest in the form of abnormal liver function tests to cirrhosis to hepato cellular carcinoma. Onset of liver disease in such patients can go unnoticed for years if only synthetic function of liver is looked at or till the clinical symptoms appear.
Adhi Arya, Sushil Azad, S. Radhakrishnan
openaire   +1 more source

Fontan‐associated liver disease

Hepatology, 2022
Moira B. Hilscher, Michael L. Wells, Sudhakar K. Venkatesh, Frank Cetta, Patrick S. Kamath   +4 more
openaire   +4 more sources